Rebel shareholders failed to win any of their three resolutions, including the removal of the chief executive, at the requisitioned general meeting of ProBiotix Health (LON: PBX). Broker Peterhouse said that major shareholder OptiBiotix Health (LON: OPTI) was not allowed to vote its shares at the meeting because of the relationship agreement from the flotation of the probiotics developer. OptiBiotix Health owns 53.5 million shares, and the votes were lost by less than 36 million shares. The ProBiotix Health share price recovered 45% to 7.25p. The recent £1.23m fundraising was at 3.36p/share.
Mendell Helium (LON: MDH) has sent a circular seeking shareholder approval for the sale of its cannabis operations. The meeting will be held on 11 November. The plan is to take up the option to acquire M3 Helium and seek readmission. The share price rose 14% to 3.25p.
Surgical treatments provider One Health Group (LON: OHGR) interim revenues were more than one-fifth higher at £13.4m. New patients increased by 29%. The second half is likely to better than expected. That means that full year EBITDA should be higher than £1.9bn. There was cash of £4.9m at the end of September 2024. A move to AIM is being considered. The share price firmed 7.69% to 210p.
KR1 (LON: KR1) had net assets of 62.15p/share at the end of September 2024. The income from digital assets was £592,000 during September. The share price increased 5.15% to 51p.
Aquis Exchange (LON; AQX) and Cboe Europe are assessing a joint bid to provide an EU consolidated tape of stock trades. The European Commission has decided to create a single entity to operate a real-time, trade consolidated tape. The European Securities and Market Authority will select the business to take on the role. The plan is for the two companies to set up a joint venture called SimpliCT, which will be based in the Netherlands, to bid for the role of equity consolidated tape provider. The share price is 2.8% higher at 330p.
Luxury prize draw organiser Good Life Plus (LON: GDLF) has achieved £330,000 in monthly recurring revenues. There are more than 40,000 subscribers and churn has been reduced. In the six months to July 2024, revenues were £1.69m. There was a £2.21m cash outflow from operating activities. There was a fundraising after the balance sheet date. Richard Johnston has been appointed as finance director. The share price edged up 2.38% to 2.15p.
FALLERS
Investment Evolution Credit (LON: IEC) raised £475,000 at 1p each and there is a broker option to issue up to three million more shares. The share price declined 68.8% to 12.5p.
Incanthera (LON: INC) is still waiting on the launch date for Skin + CELL products.This delay knocked 13.4% off the share price to 14.5p. .
Health IT provider DXS International (LON: DXSP) has won its first NHS commercial contract for its AI ExpertCare Clinical Decision Support product. In the year to April 2024, revenues were 2% ahead at £3.31m, There was an impairment charge of £4.38m. Even without that write-down the company fell into loss. Chairman Bob Sutcliffe bought 50,000 shares at 1p each and 133,333 shares at 1.5p each. He owns 1.74% of the company. The share price dipped 11.1% to 1p.
Marula Mining (LON: MARU) is stockpiling ore at the Kinusi copper mine. Samples have been sent to South Africa for test work and the results will help to design the first phase of the processing facilities. Three trial shipments are about to be sold. The share price fell 10.6% to 5.25p.
Hannah Haxby has resigned as a non-executive director of Hydrogen Future Industries (LON: HFI). The share price slid 7.14% to 1.625p.
Macaulay Capital (LON: MCAP) investee company Vale Foods has repaid a £125,000 loan and this has been reinvested in shares in the latest fundraising of £430,000. A £100,000 loan has been made to another investee company. The share price declined 5.26% to 18p.
Chris Akers’ stake in Oscillate (LON: MUSH) has been reduced from 5.94% to less than 3%. Peterhouse Capital has also reduced its stake below 3%. The share price slipped 4.35% to 1.1p.
Fenikso (LON: FNK) is launching a share buyback of up to 49.3 million shares. A further $404,000 has been received in loan repayments. The remaining loan is worth nearly $39m. The share price fell 3.45% to 1.4p.
Ananda Developments (LON: ANA) lost £1.21m in the six months to July 2024 and has net liabilities due to convertible loans that mature in November 2025. The share price edged down 1.54% to 0.32p.